Literature DB >> 22407392

Frequency and risk factors for neovascular glaucoma after vitrectomy in eyes with proliferative diabetic retinopathy.

Akiko Goto1, Masaru Inatani, Toshihiro Inoue, Nanako Awai-Kasaoka, Yuji Takihara, Yasuhiro Ito, Mikiko Fukushima, Hidenobu Tanihara.   

Abstract

PURPOSE: To investigate the rate and risk factors for neovascular glaucoma (NVG) after vitrectomy in proliferative diabetic retinopathy (PDR).
METHODS: Five hundred and twelve patients (512 eyes) with PDR who underwent vitrectomy between January 1, 2003 and June 30, 2009 at Kumamoto University Hospital, Japan, were retrospectively evaluated. Postoperative NVG was defined as neovascularization in the anterior segment and intraocular pressure (IOP) ≥ 22 mm Hg after vitrectomy. Kaplan-Meier survival analysis was applied to calculate the rate of NVG after vitrectomy. Risk factors for NVG after vitrectomy were identified by multivariable analysis using the Cox proportional hazards model.
RESULTS: The mean follow-up period was 422 days. Twenty-seven of 512 patients (5.3%) developed postoperative NVG after vitrectomy. The probability of NVG occurrence at 6 and 12 months after vitrectomy was 6.0% and 7.1%, respectively. Male sex [relative risk (RR)=4.247; P=0.0032), younger age (RR=0.956/y; P=0.0237), higher baseline IOP (RR=1.203/mm Hg; P=0.0335), preoperative neovascularization in the anterior chamber angle (RR=8.899; P<0.0001), and presence of NVG in the fellow eye (RR=5.355; P=0.0013) were significant risk factors for postoperative NVG.
CONCLUSIONS: The frequency of NVG in PDR eyes within 1 year after vitrectomy was estimated as 7.1%. The risk is independently associated with male sex, younger age, higher baseline IOP, preoperative neovascularization in the angle, and NVG in the fellow eye.

Entities:  

Mesh:

Year:  2013        PMID: 22407392     DOI: 10.1097/IJG.0b013e31824d514a

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  17 in total

1.  Ahmed valve implantation for neovascular glaucoma after 23-gauge vitrectomy in eyes with proliferative diabetic retinopathy.

Authors:  Yu Cheng; Xiao-Hong Liu; Xi Shen; Yi-Sheng Zhong
Journal:  Int J Ophthalmol       Date:  2013-06-18       Impact factor: 1.779

2.  Pars Plana Ahmed Valve Implantation for Vitrectomized Eyes With Refractory Glaucoma.

Authors:  Xiaoli Xiang; Pan Xiao; Jingjing Yu; Yihong Cao; Tingwang Jiang; Zhengru Huang
Journal:  Front Med (Lausanne)       Date:  2022-04-25

3.  Ocular findings, surgery details and outcomes in proliferative diabetic retinopathy patients with chronic kidney disease.

Authors:  Jipeng Li; Aman Chandra; Lin Liu; Lin Zhang; Jun Xu; Meng Zhao
Journal:  PLoS One       Date:  2022-10-21       Impact factor: 3.752

4.  Hydrogen sulfide serves as a biomarker in the anterior segment of patients with diabetic retinopathy.

Authors:  Yuyi Han; Xiaoqian Zhang; Zhiyin Zhou; Mengxi Yu; Qiuhong Wang; Jin Yao; Yi Han
Journal:  Int Ophthalmol       Date:  2020-01-01       Impact factor: 2.031

5.  Neovascular glaucoma after vitrectomy in patients with proliferative diabetic retinopathy.

Authors:  Jin-Woo Kwon; Donghyun Jee; Tae Yoon La
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

6.  Intravitreal Ranibizumab Injection as an Adjuvant in the Treatment of Neovascular Glaucoma Accompanied by Vitreous Hemorrhage after Diabetic Vitrectomy.

Authors:  Xi Shen; Yanwei Chen; Yanuo Wang; Lu Yang; Yisheng Zhong
Journal:  J Ophthalmol       Date:  2016-05-16       Impact factor: 1.909

7.  Outcomes of 23-Gauge Vitrectomy Combined with Phacoemulsification, Panretinal Photocoagulation, and Trabeculectomy without Use of Anti-VEGF Agents for Neovascular Glaucoma with Vitreous Hemorrhage.

Authors:  Hua Yan
Journal:  J Ophthalmol       Date:  2016-01-17       Impact factor: 1.909

8.  Prognostic Factor Analysis of Intraocular Pressure with Neovascular Glaucoma.

Authors:  Satoko Nakano; Takako Nakamuro; Katsuhiko Yokoyama; Kunihiro Kiyosaki; Toshiaki Kubota
Journal:  J Ophthalmol       Date:  2016-08-14       Impact factor: 1.909

Review 9.  Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss.

Authors:  Ryan Lee; Tien Y Wong; Charumathi Sabanayagam
Journal:  Eye Vis (Lond)       Date:  2015-09-30

10.  Ahmed Glaucoma Valve Implantation in Vitrectomized Eyes.

Authors:  Nimet Yeşim Erçalık; Serhat İmamoğlu
Journal:  J Ophthalmol       Date:  2018-05-10       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.